Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Gel Manufacturing: SOP for Reporting Quality Control Results for Gels – V 2.0

Posted on By

Gel Manufacturing: SOP for Reporting Quality Control Results for Gels – V 2.0

Standard Operating Procedure for Reporting Quality Control Results of Gel Products


Department Gel Manufacturing
SOP No. SOP/GM/070/2025
Supersedes SOP/GM/070/2022
Page No. Page 1 of 10
Issue Date 02/06/2025
Effective Date 04/06/2025
Review Date 02/06/2026

1. Purpose

To outline the standardized procedure for compiling, reviewing, and reporting quality control (QC) test results of gel formulations to ensure that all results are accurately recorded, approved, and communicated.

2. Scope

This SOP is applicable to all finished and semi-finished gel batches manufactured and tested

in the Quality Control department of the pharmaceutical facility.

3. Responsibilities

  • QC Analyst: Perform testing and record raw data.
  • QC Reviewer: Review raw data and calculations for accuracy.
  • QA Officer: Verify final reports before release.
See also  Gel Manufacturing: SOP for Waste Management of Gel Manufacturing Byproducts - V 2.0

4. Accountability

The Quality Control Head is accountable for implementation and compliance of the procedure.

5. Procedure

5.1 Test Execution and Data Entry

  1. Perform QC tests as per approved specifications for the gel product.
  2. Record observations and readings immediately in raw data sheets or electronic systems.
  3. Ensure all entries are legible, dated, and signed.

5.2 Data Review

  • Reviewer shall verify raw data for completeness and accuracy.
  • Recheck calculations and units for correctness.
  • Verify that the results meet specifications.

5.3 Report Compilation

  1. Transfer approved data to the Final QC Report format (Annexure-1).
  2. Attach test protocols, chromatograms, and calculations where applicable.
  3. Obtain signatures from the Analyst and Reviewer.
See also  Gel Manufacturing: SOP for Bulk Storage of Gels - V 2.0

5.4 Communication of Results

  • Submit final QC report to QA for verification.
  • Share test report with Production and Warehouse if batch clearance is required.
  • In case of Out of Specification (OOS) results, follow SOP for OOS handling.

5.5 Report Storage and Archival

  • Maintain soft and hard copies of reports for a minimum of 5 years.
  • Store in locked and humidity-controlled archive room.

6. Abbreviations

  • QC: Quality Control
  • QA: Quality Assurance
  • OOS: Out of Specification
  • SOP: Standard Operating Procedure

7. Documents

  1. Final QC Report Format – Annexure-1
  2. Raw Data Recording Sheet – Annexure-2

8. References

  • ICH Q6A: Specifications – Test Procedures and Acceptance Criteria
  • 21 CFR Part 211 – cGMP for Finished Pharmaceuticals
See also  Gel Manufacturing: SOP for Immediate Corrective Actions in Case of Deviations - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Jr. Production Chemist QA Executive Head – Manufacturing
Department Gel Manufacturing Quality Assurance Manufacturing

11. Annexures

Annexure-1: Final QC Report Format

Product Name
Batch No.
Test Performed Result Specification Status (Pass/Fail)
Appearance
pH
Viscosity
Assay
Microbial Test
Preservative Efficacy

Annexure-2: Raw Data Recording Sheet


Test Name Observed Value Date Analyst Signature

Revision History

Revision Date Revision No. Change Description Reason Approved By
20/06/2022 1.0 Initial version New SOP QA Head
02/06/2025 2.0 Added detailed annexure formats Compliance Update QA Head
Gels V 2.0 Tags:gel excipients SOP, gel extrudability SOP, gel formulation process guidelines, gel formulation safety SOP, gel formulation SOP template, gel homogenization SOP, gel ingredient weighing SOP, gel labeling and documentation SOP, gel microbial contamination SOP, gel packaging SOP, gel viscosity measurement SOP, gel viscosity testing SOP, pharmaceutical gel SOP, quality control SOP gel formulations, SOP for carbopol gel formulation, SOP for gel pH adjustment, SOP for gel spreadability test, stability testing SOP gel, standard operating procedure gel preparation, topical gel manufacturing SOP

Post navigation

Previous Post: Analytical Method Development: Structural Elucidation by NMR – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Online Inspection during Injectable Manufacturing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version